Related Experiment Video
Updated: Jan 18, 2026
14:45
Analyzing the Parkinson's Disease Mouse Model Induced by Adeno-associated Viral Vectors Encoding Human α-Synuclein
Published on: July 29, 2022
6.5K
MicroRNAs and synaptic dysfunction in Parkinson's disease
Morgan N Ogwo1, Bhupender Sharma1, Gunjan Goyal1
1Center of Emphasis in Neuroscience, Department of Molecular and Translational Medicine, Paul L. Foster School of Medicine, Texas Tech University Health Sciences Center El Paso, El Paso, TX 79905, USA.
Molecular Therapy. Nucleic Acids
|September 8, 2025
Summary
Synaptic microRNAs (miRNAs) are crucial for normal brain function and are implicated in Parkinson's disease (PD) pathology. Understanding their role may reveal new treatment strategies for this neurodegenerative condition.
Area of Science:
- Neuroscience
- Molecular Biology
- Genetics
Background:
- Parkinson's disease (PD) is a neurodegenerative disorder characterized by synaptic dysfunction.
- Synaptic health is essential for proper neurotransmission, and its impairment is central to PD pathogenesis.
- MicroRNAs (miRNAs), particularly those within neuronal subcellular compartments, are increasingly recognized for their role in neurological diseases.
Purpose of the Study:
- To review the role of synaptic microRNAs (miRNAs) in Parkinson's disease (PD).
- To highlight miRNAs critical for normal synapse function and their involvement in PD pathology.
- To explore the interplay between synaptic miRNAs and PD-associated synaptic dysfunction.
Main Methods:
- Literature review focusing on synaptic miRNAs and their relevance to PD.
- Analysis of current research on miRNA regulation of synaptic proteins.
- Discussion of the impact of synaptic miRNAs on PD pathogenesis.
Main Results:
- Synaptic miRNAs are vital regulators of synaptic activity and function.
- Dysregulation of specific synaptic miRNAs is linked to PD pathology.
- These miRNAs influence key synaptic proteins implicated in neurodegeneration.
Conclusions:
- Synaptic miRNAs represent a promising area for understanding PD etiology.
- Further investigation into synaptic miRNAs could unveil novel therapeutic targets for PD.
- Targeting synaptic miRNAs may offer new avenues for treating Parkinson's disease.
Keywords:
Alpha-synucleinCerebral cortexDopaminergicMT: Non-coding RNAsMicroRNAsParkinson’s diseaseStriatumSubstantia nigraSynapseSynaptic plasticityMore Related Videos
Related Concept Videos
01:37Neural Regulation
43.2K
Digestion begins with a cephalic phase that prepares the digestive system to receive food. When our brain processes visual or olfactory information about food, it triggers impulses in the cranial nerves innervating the salivary glands and stomach to prepare for food.
43.2K
01:15Parkinson's Disease: Overview
1.8K
Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is...
1.8K
01:24Parkinson's Disease: Treatment
995
Neurodegenerative disorders, such as Parkinson's Disease (PD), involve the gradual and irreversible destruction of neurons in particular brain areas. These disorders exhibit standard features like proteinopathies, selective vulnerability of some neurons, and an interaction of intrinsic properties, genetics, and environmental influences in neural injury.
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
995
01:22Lysosomal Hydrolases
4.4K
Lysosomes are the site for the degradation of macromolecules and biological polymers released during membrane trafficking events such as secretory, endocytic, autophagic, and phagocytic pathways. The membrane-enclosed area of the lysosome, called the lumen, contains hydrolytic enzymes active in an acidic environment. These acid hydrolases are functional at a pH between 4.5 and 5 and are involved in cellular processes such as cell signaling, energy metabolism, restoration of the plasma membrane,...
4.4K